Evidence map›Paper›PMID 8863159›Full record

ArticleJournal of medical genetics1996

Characterisation of four novel fibrillin-1 (FBN1) mutations in Marfan syndrome.

L C Adès, E A Haan, A F Colley, R I Richard

Open access · bronzeAbstract readCase Reports
In one paragraph

Article in Journal of medical genetics, 1996. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.9field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 27 citations in OpenAlex.

  1. Thumb duplication: molecular analysis of different clinical types.European journal of orthopaedic surgery & traumatology : orthopedie traumatologie · 2019
    Article
  2. Review
  3. Dural ectasia in Marfan syndrome: a case control study.AJNR. American journal of neuroradiology · 2009
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

L C AdèsDepartment of Medical Genetics, Women's and Children's Hospital, North Adelaide, SA, Australia.
E A Haan
A F Colley
R I Richard
Women's and Children's Hospital · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Forty-four percent of the fibrillin-1 gene (FBN1) from 19 unrelated families with Marfan syndrome was screened for putative mutations by single strand conformational polymorphism (SSCP) analysis. Four novel mutations were identified and characterised in five people, three with classical Marfan syndrome (two from one family, and one from an unrelated family), one with a more severe phenotype, and one with neonatal Marfan syndrome. The base substitutions G2113A, G2132A, T3163G, and G3458A result in amino acid substitutions A705T, C711Y, C1055G, and C1152Y, respectively. C711Y, C1055G, and C1152Y lead to replacement of a cysteine by another amino acid; the latter two occur within epidermal growth factor-like motifs in exon 25 and 27, respectively. The A705T mutation occurs at exon 16 adjacent to the GT splice site. The A705T and C711Y mutations, at exon 16 and 17, respectively, are the first documented in the second transforming growth factor-beta 1 binding protein-like motif of FBN1.

Indexed as

AdipokinesAdultChildChild, PreschoolDNA Mutational AnalysisExonsFemaleFibrillin-1FibrillinsGenesHumansInfant, NewbornMaleMarfan SyndromeMicrofilament ProteinsMolecular Sequence DataAdipokinesFBN1 protein, humanFibrillin-1FibrillinsMicrofilament Proteins

Identifiers

PMID8863159
PMCPMC1050701
OpenAlexW2146789646

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.